201 related articles for article (PubMed ID: 36998056)
1. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
2. Integrative analyses reveal biological function and prognostic role of m7G methylation regulators in high-grade glioma.
Li X; Li Y; Li N; Shen L; Li Z
Aging (Albany NY); 2023 Sep; 15(17):8782-8799. PubMed ID: 37679037
[TBL] [Abstract][Full Text] [Related]
3. Exploration and validation of m7G-related genes as signatures in the immune microenvironment and prognostic indicators in low-grade glioma.
Zhen W; Shan X; Cui X; Ji P; Zhang P; Wang M; Cai Z
Am J Transl Res; 2023; 15(6):3882-3899. PubMed ID: 37434820
[TBL] [Abstract][Full Text] [Related]
4. Identification of m7G-related hub biomarkers and m7G regulator expression pattern in immune landscape during the progression of osteoarthritis.
Chen Z; Hua Y
Cytokine; 2023 Oct; 170():156313. PubMed ID: 37549488
[TBL] [Abstract][Full Text] [Related]
5. Integrative analyses reveal prognostic and immunogenic characteristics of m7G methylation regulators in patients with glioma.
Tang L; Li Y; Shen L; Li N; Shen L; Li Z
Am J Transl Res; 2023; 15(1):288-309. PubMed ID: 36777864
[TBL] [Abstract][Full Text] [Related]
6. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
7. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
8. A novel m7G regulator-based methylation patterns in head and neck squamous cell carcinoma.
Ying Y; Zhang W; Zhu H; Luo J; Xu X; Yang S; Zhao Y; Zhang Z
Mol Carcinog; 2023 Dec; 62(12):1902-1917. PubMed ID: 37642290
[TBL] [Abstract][Full Text] [Related]
9. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
10. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
11. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
12. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.
Huang X; Chen Z; Xiang X; Liu Y; Long X; Li K; Qin M; Long C; Mo X; Tang W; Liu J
EPMA J; 2022 Dec; 13(4):671-697. PubMed ID: 36505892
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma.
Zhu Y; Zhao Z; Thandar M; Cheng J; Chi P; Huang S
BMC Gastroenterol; 2023 Jan; 23(1):22. PubMed ID: 36681801
[TBL] [Abstract][Full Text] [Related]
15. Positive regulators of T cell functions as predictors of prognosis and microenvironment characteristics of low-grade gliomas.
Li Y; Feng Y; Luo F; Peng G; Li Y
Front Immunol; 2022; 13():1089792. PubMed ID: 36726969
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data.
Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F
J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of m
Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
Front Immunol; 2022; 13():955848. PubMed ID: 36203569
[TBL] [Abstract][Full Text] [Related]
18. Identification of N7-methylguanosine-related miRNAs as potential biomarkers for prognosis and drug response in breast cancer.
Dai D; Zhuang H; Shu M; Chen L; Long C; Wu H; Chen B
Heliyon; 2024 Apr; 10(8):e29326. PubMed ID: 38628712
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
20. Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas.
Maimaiti A; Aili Y; Turhon M; Kadeer K; Aikelamu P; Wang Z; Niu W; Aisha M; Kasimu M; Wang Y; Wang Z
Front Mol Biosci; 2022; 9():844973. PubMed ID: 35359593
[No Abstract] [Full Text] [Related]
[Next] [New Search]
